Evaluating Plasma Pharmacokinetics of Intravenous Iron Formulations: Judging Books by Their Covers? Amy Barton Pai Commentary 02 December 2014 Pages: 323 - 324
Oral Bioavailability: Issues and Solutions via Nanoformulations Kamla PathakSmita Raghuvanshi Review Article 11 February 2015 Pages: 325 - 357
Placental Transfer of Antidepressant Medications: Implications for Postnatal Adaptation Syndrome Grace EwingYekaterina TatarchukDeborah Kim Review Article 25 February 2015 Pages: 359 - 370
A Review of Pharmacokinetic Drug–Drug Interactions with the Anthelmintic Medications Albendazole and Mebendazole Shane Ashley PawlukCraig Allan RoelsMary H. H. Ensom Review Article 18 February 2015 Pages: 371 - 383
Population Pharmacokinetic Meta-Analysis to Bridge Ferumoxytol Plasma Pharmacokinetics Across Populations Nele PlockAxel FaciusPau Aceves Original Research Article Open access 05 November 2014 Pages: 385 - 395
Population Pharmacokinetic-Pharmacodynamic Modelling of 24-h Diastolic Ambulatory Blood Pressure Changes Mediated by Axitinib in Patients with Metastatic Renal Cell Carcinoma Ying ChenBrian I. RiniYazdi K. Pithavala Original Research Article 25 October 2014 Pages: 397 - 407
Comparing Dosage Adjustment Methods for Once-Daily Tobramycin in Paediatric and Adolescent Patients with Cystic Fibrosis Stefanie HennigFranziska HolthouseChristine E. Staatz Original Research Article 18 November 2014 Pages: 409 - 421
Influence of Sex and Race on Mycophenolic Acid Pharmacokinetics in Stable African American and Caucasian Renal Transplant Recipients Kathleen M. TornatoreCalvin J. MeaneyRocco C. Venuto Original Research Article 16 December 2014 Pages: 423 - 434
Population Pharmacokinetic Modeling of Thymoglobulin® in Children Receiving Allogeneic-Hematopoietic Cell Transplantation: Towards Improved Survival Through Individualized Dosing Rick AdmiraalCharlotte van KesterenCatherijne A. J. Knibbe Original Research Article 03 December 2014 Pages: 435 - 446
Comment on: “Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus” Emanuel RaschiElisabetta PoluzziFabrizio De Ponti Letter to the Editor 27 February 2015 Pages: 447 - 448
Author’s Reply to De Ponti et al.: “Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus” André J. Scheen Letter to the Editor 27 February 2015 Pages: 449 - 451
Erratum to: Kinetically Guided Neoadjuvant Chemoradiotherapy Based on 5-Fluorouracil in Patients with Locally Advanced Rectal Cancer Jiří GrimMiloš HrochJiřina Martínková Erratum 20 March 2015 Pages: 453 - 453
Erratum to: Application of Modeling and Simulation to a Long-Term Clinical Trial: A Direct Comparison of Simulated Data and Data Actually Observed in Japanese Osteoporosis Patients Following 3-Year Ibandronate Treatment Kiyohiko NakaiSatofumi IidaTakehiko Kawanishi Erratum 20 March 2015 Pages: 455 - 455